Development of First Lead Structures for Phosphoinositide 3-Kinase-C2γ Inhibitors

Anne Freitag, Prajwal Prajwal, Aliaksei Shymanets, Christian Harteneck, Bernd Nürnberg, Christoph Schächtele, Michael H.G. Kubbutat, Frank Totzke, Stefan Laufer

Journal of Medicinal Chemistry · 2014 · 27 citations · 17 references

DOIFull text

Open access

Concepts

Abstract

The importance of complete elucidation of the biological functions of phosphoinositide 3-kinases (PI3K) was realized years ago. They generate 3-phosphoinositides, which are known to function as important second messengers in many inter- and intracellular signaling pathways. However, the functional role of class II PI3Ks is still unclear. Herein, we describe the synthesis of a panel of compounds that were tested against all eight mammalian PI3K-isoforms. We found inhibitors with some selectivity for class II PI3K-C2γ and also compounds with preferred inhibition of class II PI3K-C2β, providing structural leads to develop selective tool compounds.

References

17